BM
Basavaraju Manjunath
About Basavaraju Manjunath
Data last updated:
Basavaraju Manjunath is a Director at Fif Medlabs India Private Limited (since 2022). The company operates in Chemicals. Fif Medlabs India Private Limited reported revenue of ₹56.6 Lakh (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 25 Nov 2022 | 2021 | ₹56.6 Lakh (FY 2024) | Active |
Board colleagues of Basavaraju Manjunath
| Name | DIN | Company | Designation |
|---|---|---|---|
| Kopparam Sathyanarayana Setty Krishna Prasad | 09452492 | Fif Medlabs India Private Limited | Director |
| Manju Srungarasagara Hutchaih | 09452490 | Fif Medlabs India Private Limited | Director |
| Papanna Prasad | 09804787 | Fif Medlabs India Private Limited | Director |
| Prakash Shankreppa Mattikoppa | 09804722 | Fif Medlabs India Private Limited | Director |
| Segu Nanjundaiah Manjunatha | 09452491 | Fif Medlabs India Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Basavaraju Manjunath
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Basavaraju Manjunath
Basavaraju Manjunath currently holds 1 directorship: Fif Medlabs India Private Limited (Director, since 25 Nov 2022, revenue ₹56.6 Lakh (FY 2024)).
Basavaraju Manjunath was first appointed on 25 Nov 2022 as Director at Fif Medlabs India Private Limited.
The current boards of Basavaraju Manjunath's companies include Kopparam Sathyanarayana Setty Krishna Prasad (Fif Medlabs India Private Limited), Manju Srungarasagara Hutchaih (Fif Medlabs India Private Limited), Papanna Prasad (Fif Medlabs India Private Limited), Prakash Shankreppa Mattikoppa (Fif Medlabs India Private Limited), Segu Nanjundaiah Manjunatha (Fif Medlabs India Private Limited).